Today: 13 June 2026
Micron stock slips in early trade despite S&P credit upgrade as investors eye March 18 results
27 February 2026
1 min read

Micron stock slips in early trade despite S&P credit upgrade as investors eye March 18 results

New York, February 27, 2026, 10:01 EST — Regular session

  • Micron shares slipped roughly 0.8% in early Friday action, falling alongside a wider tech pullback.
  • S&P bumped Micron up to BBB, citing improved AI-fueled cash flow and tagging the outlook as positive.
  • Rising memory prices are clouding the outlook for smartphone shipments, introducing fresh concerns for demand.

Micron Technology, Inc. slipped roughly 0.8% to $412.09 early Friday in New York, extending losses after dropping 3.1% the day before. Shares swung from $401.20 up to $412.98 as both the S&P 500 and Nasdaq each dropped close to 1%.

S&P Global Ratings bumped Micron’s credit score up to BBB from BBB- Thursday, highlighting AI-fueled expansion and stronger cash flow. The agency’s note points to lessening capital spending as price gains kick up operating cash, projecting Micron will have more than $10 billion on hand in fiscal 2026—though buybacks stay capped due to U.S. CHIPS Act restrictions. S&P also cited high-bandwidth memory (HBM) as a key tailwind, with Micron’s HBM inventory reportedly spoken for through calendar 2026.

The upgrade comes as higher memory prices make their presence felt in key end markets for Micron—phones included. On Thursday, IDC projected the global smartphone market will face its steepest yearly drop in 2026, citing sharply higher memory costs driving up device prices. The group described the effect as a “tsunami-like shock” from the memory supply chain. Reuters

Risk-off dominated Friday, with U.S. stocks retreating as inflation jitters resurfaced and talk picked up again about AI’s pace in reshaping sector profits. Volatility hit chipmakers and software stocks hardest.

Micron’s getting fresh attention in India, where Prime Minister Narendra Modi will inaugurate the company’s ATMP facility—assembly, testing, marking and packaging—in Sanand, Gujarat this Saturday, according to local media. CEO Sanjay Mehrotra, for his part, called memory and storage “central to modern computing,” pointing to surging AI demand. The Times of India

Micron’s fiscal Q2 results hit on March 18, with the earnings call set for 2:30 p.m. Mountain. Investors are keyed in on any shifts in memory pricing, supply constraints, and the split between data center demand and consumer device sales.

Traders face a straightforward but tough dilemma: will the AI ramp-up keep memory supplies tight enough to justify current prices, or are buyers about to balk as expenses climb?

The bearish voices are growing. Should handset demand weaken more rapidly than suppliers anticipate, or if mainstream DRAM and NAND prices lose steam, Micron’s cash-flow narrative could get messy fast. The market hasn’t hesitated to react sharply at the first sign of a cycle shift.

Eyes are on the India ramp this weekend for potential signals, though the true inflection point for the stock comes March 18, as Micron’s earnings and guidance will shape sentiment for the remainder of the quarter.

Stock Market Today

  • CSL Shares Rise 9.8% After FY26 Guidance Cut on Impairments and Channel Shifts
    June 13, 2026, 5:50 AM EDT. CSL (ASX:CSL) shares climbed 9.8% following a downward revision of its FY26 revenue and profit forecasts. The revision reflects impairments and writedowns linked to changes in U.S. immunoglobulin sales channels and weakening albumin prices in China. Despite these challenges, investor sentiment shows cautious optimism about CSL's operational turnaround prospects. The market now awaits CSL's full-year results and dividend update on 18 August 2026, which will offer clarity on revenue trends and any further impairments. CSL projects FY29 revenue of US$16.9 billion and earnings of US$3.3 billion, suggesting a potential 31% upside to current share prices. However, risks remain around sustained margin pressure and additional write-downs in plasma and albumin segments.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 13.06.2026

13 June 2026
LIVEMarkets rolling coverageStarted: June 13, 2026, 4:00 AM EDTUpdated: June 13, 2026, 6:14 AM EDT CSL Shares Rise 9.8% After FY26 Guidance Cut on Impairments and Channel Shifts June 13, 2026, 5:50 AM EDT. CSL (ASX:CSL) shares climbed 9.8% following a downward revision of its FY26 revenue and profit forecasts. The revision reflects impairments and writedowns linked to changes in U.S. immunoglobulin sales channels and weakening albumin prices in China. Despite these challenges, investor sentiment shows cautious optimism about CSL’s operational turnaround prospects. The market now awaits CSL’s full-year results and dividend update on 18 August 2026, which will offer
SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal
Previous Story

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal

CBA’s $1 Billion Mortgage Fraud Alarm: Big Banks Face New AI-Document Threat
Next Story

CBA’s $1 Billion Mortgage Fraud Alarm: Big Banks Face New AI-Document Threat

Go toTop